Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Evotec SE

Start price
Target price
Perf. (%)
€6.14
01:25
-
05.10.25
-
04.10.24

Evotec SE

Start price
Target price
Perf. (%)
€6.11
02.10.24
€7.00
02.10.25
-1.39%
03.10.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Valuable balance sheet
buy
Fresenius Medical Care AG & Co KGaA ADR

Start price
Target price
Perf. (%)
€18.90
30.09.24
-
30.09.25
0.53%
03.10.24

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€0.84
28.09.24
-
28.09.25
-
28.09.24

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Merck KGaA

Start price
Target price
Perf. (%)
€161.00
26.09.24
-
26.09.25
-3.54%
04.10.24

buy
Merck KGaA

Start price
Target price
Perf. (%)
€155.90
24.09.24
-
24.09.25
-0.38%
04.10.24

buy
Fresenius Medical Care AG & Co KGaA ADR

Start price
Target price
Perf. (%)
€17.90
22.09.24
-
22.09.25
6.15%
03.10.24

buy
Merck KGaA

Start price
Target price
Perf. (%)
€159.55
20.09.24
-
20.09.25
-2.66%
04.10.24

buy
Bayer AG ADR

Start price
Target price
Perf. (%)
€7.05
20.09.24
€5.00
20.09.25
4.26%
28.09.24

High valuation
Low dividend yield expected
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Bayer AG ADR

Start price
Target price
Perf. (%)
€6.85
18.09.24
€5.00
18.09.25
2.92%
20.09.24

High valuation
Low dividend yield expected
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Fresenius Medical Care AG & Co KGaA ADR

Start price
Target price
Perf. (%)
€18.80
14.09.24
-
14.09.25
1.06%
03.10.24

Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€2.20
12.09.24
-
12.09.25
-3.87%
14.09.24

Probably not worthwhile Investment
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.55
09.09.24
-
09.09.25
-
08.03.24

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.55
06.09.24
€8.99
06.09.25
-
08.03.24

Bayer AG ADR

Start price
Target price
Perf. (%)
€6.90
03.09.24
€7.00
03.09.25
-0.72%
18.09.24

High valuation
Low dividend yield expected
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Evotec SE

Start price
Target price
Perf. (%)
€6.60
02.09.24
€7.00
02.09.25
-7.43%
02.10.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Valuable balance sheet
buy
Evotec SE

Start price
Target price
Perf. (%)
€5.90
26.08.24
-
26.08.25
4.07%
04.10.24

buy
Evotec SE

Start price
Target price
Perf. (%)
€5.76
20.08.24
-
20.08.25
15.81%
29.08.24

Risky Investment
Revenue decline/stagnation expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€25.96
08.08.24
-
08.09.24
11.90%
09.09.24

Higher EBIT margin than peer group
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Fair valuation
buy
Merck KGaA

Start price
Target price
Perf. (%)
€167.85
01.08.24
€190.00
01.08.25
-7.48%
04.10.24

Bayer AG

Start price
Target price
Perf. (%)
€27.16
23.07.24
€20.00
23.07.25
-6.13%
07.08.24

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Sartorius AG ST

Start price
Target price
Perf. (%)
€174.80
21.07.24
€155.00
21.07.25
8.12%
04.10.24

buy
Geratherm Medical AG

Start price
Target price
Perf. (%)
€4.04
14.07.24
€5.50
14.07.25
-2.48%
21.07.24

buy
Biofrontera AG

Start price
Target price
Perf. (%)
€0.33
14.07.24
€0.45
14.07.25
-
21.07.24

buy
Biofrontera AG

Start price
Target price
Perf. (%)
€0.33
14.07.24
€0.45
14.07.25
-
21.07.24